Polymorphic CAG repeats in the androgen receptor gene, prostate-specific antigen polymorphism and prostate cancer risk

Carcinogenesis

Volumn 23, Issue 10, 2002, Pages 1647-1651

  Gsur, Andrea ^a   Preyer, Martin ^a   Haidinger, Gerald ^a   Zidek, Thomas ^a   Madersbacher, Stephan ^b   Schatz, Georg ^b   Marberger, Michael ^b   Vutuc, Christian ^a   Micksche, Michael ^a  

^a Institute of Cancer Research   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ANDROGEN; ANDROGEN RECEPTOR; CYTOSINE; DNA; GUANINE; PROSTATE SPECIFIC ANTIGEN;

ADVANCED CANCER; AGED; ALLELE; ARTICLE; AUSTRIA; BINDING AFFINITY; CALCULATION; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA RESPONSIVE ELEMENT; EXON; GENE SEQUENCE; GENE TARGETING; GENETIC TRANSCRIPTION; GENOTYPE; HUMAN; HYPOTHESIS; LEUKOCYTE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; SCORING SYSTEM; STATISTICAL ANALYSIS; TRANSCRIPTION REGULATION;

EID: 0036797119     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/23.10.1647     Document Type: Article

References (32)

1. Ross,R.K., Coetzee,G.A., Pearce,C.L., Reichardt,J.K., Bretsky,P., Kolonel,L.N., Henderson,B.E., Lander,E., Altshuler,D. and Daley,G. (1999) Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility. Eur Urol., 35, 355-361.
2. Brown,C.J., Goss,S.J., Lubahn,D.B., Joseph,D.R., Wilson,E.M., French,F.S. and Willard,H.F. (1989) Androgen receptor locus on the human X chromosome: regional localization to Xq11-12 and description of a DNA polymorphism. Am. J. Hum. Genet., 44, 264-269.
3. Monroe,K.R., Yu,M.C., Kolonel,L.N., Coetzee,G.A., Wilkens,L.R., Ross,R.K. and Henderson,B.E. (1995) Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nat. Med., 1, 827-829.
4. Xu,J., Meyers,D., Freije,D. et al. (1998) Evidence for a prostate cancer susceptibility locus on the X chromosome. Nature Genet., 20, 175-179.
5. Lange,E.M., Chen,H., Brierley,K., Perrone,E.E., Bock,C.H., Gillanders,E., Ray,M.E. and Cooney,K.A. (1999) Linkage analysis of 153 prostate cancer families over a 30-cM region containing the putative susceptibility locus HPCX. Clin. Cancer Res., 5, 4013-4020.
6. Evans,R.M. (1988) The steroid and thyroid hormone receptor superfamily. Science, 240, 889-895.
7. Mangelsdorf,D.J., Thummel,C., Beato,M. et al. (1995) The nuclear receptor superfamily: the second decade. Cell, 83, 835-839.
8. Edwards,A., Hammond,H.A., Jin,L., Caskey,C.T. and Chakraborty,R. (1992) Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics, 12, 241-253.
9. Giovannucci,E., Stampfer,M.J., Krithivas,K., Brown,M., Dahl,D., Brufsky,A., Talcott,J., Hennekens,C.H. and Kantoff,P.W. (1997) The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc. Natl Acad. Sci. USA, 94, 3320-3323.
10. Chamberlain,N.L., Driver,E.D. and Miesfeld,R.L. (1994) The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res., 22, 3181-3186.
11. Irvine,R.A., Yu,M.C., Ross,R.K. and Coetzee,G.A. (1995) The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res., 55, 1937-1940.
12. Watt,K.W., Lee,P.J., M'Timkulu,T., Chan,W.P. and Loor,R. (1986) Human prostate-specific antigen: structural and functional similarity with serine proteases. Proc. Natl Acad Sci USA, 83, 3166-3170,
13. Cohen,P., Peehl,D.M., Graves,H.C. and Rosenfeld,R.G. (1994) Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease. J. Endocrinol., 142, 407-415.
14. Fortier,A.H., Nelson,B.J., Grella,D.K. and Holaday,J.W. (1999) Antiangiogenic activity of prostate-specific antigen. J. Natl Cancer Inst., 91, 1635-1640.
15. Rao,A. and Cramer,S.D. (1999) Identification of a polymorphism in the ARE 1 region of the PSA promotor. Proc. Am. Assoc. Cancer Res., 40, 65.
16. Xue,W., Irvine,R.A., Yu,M.C., Ross,R.K., Coetzee,G.A. and Ingles,S.A. (2000) Susceptibility to prostate cancer: interaction between genotypes at the androgen receptor and prostate-specific antigen loci. Cancer Res., 60, 839-841.
17. Richardson,T.D. and Oesterling,J.E. (1997) Age-specific reference ranges for serum prostate-specific antigen. Urol. Clin. North Am., 24, 339-351.
18. Coetzee,G.A. and Ross,R.K. (1994) Re: prostate cancer and the androgen receptor. J Natl Cancer Inst., 86, 872-873.
19. Stanford,J.L., Just,J.J., Gibbs,M., Wicklund,K.G., Neal,C.L., Blumenstein,B.A. and Ostrander,E.A. (1997) Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res., 57, 1194-1198.
20. Ingles,S.A., Ross,R.K., Yu,M.C., Irvine,R.A., La-Pera,G., Haile,R.W. and Coetzee,G.A. (1997) Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J. Natl Cancer Inst., 89, 166-170.
21. Correa-Cerro,L., Wohr,G., Haussler,J. et al. (1999) (CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German population. Eur. J. Hum. Genet., 7, 357-362.
22. Hakimi,J.M., Schoenberg,M.P., Rondinelli,R.H., Piantadosi,S. and Barrack,E.R. (1997) Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer. Clin. Cancer Res., 3, 1599-1608.
23. Lange,E.M., Chen,H., Brierley,K., Livermore,H., Wojno,K.J., Langefeld,C.D., Lange,K. and Cooney,K.A. (2000) The polymorphic exon 1 androgen receptor CAG repeat in men with a potential inherited predisposition to prostate cancer. Cancer Epidemiol. Biomarkers Prev., 9, 439-442.
24. Edwards,S.M., Badzioch,M.D., Minter,R. et al. (1999) Androgen receptor polymorphisms: association with prostate cancer risk, relapse and overall survival. Int. J. Cancer, 84, 458-465.
25. Gsur,A., Bernhofer,G., Hinteregger,S., Haidinger,G., Schatzl,G., Madersbacher,S., Marberger,M., Vutuc,C. and Micksche,M. (2000) A polymorphism in CYP17 gene is associated with prostate cancer risk. Int. J. Cancer, 87, 434-437.
26. Gsur,A., Haidinger,G., Hinteregger,S., Bernhofer,G., Schatzl,G., Madersbacher,S., Marberger,M., Vutuc,C. and Micksche,M. (2001) Polymorphisms of glutathione-S-transferase genes (GSTP1, GSTM1 and GSTT1) and prostate-cancer risk. Int. J. Cancer, 95, 152-155.
27. Berry,S.J., Coffey,D.S., Walsh,P.C. and Ewing,L.L. (1984) The development of human benign prostatic hyperplasia with age. J. Urol., 132, 474-479.
28. Mitsumori,K., Terai,A., Oka,H., Segawa,T., Ogura,K., Yoshida,O. and Ogawa,O. (1999) Androgen receptor CAG repeat length polymorphism in benign prostatic hyperplasia (BPH): correlation with adenoma growth. Prostate, 41, 253-257.
29. Giovannucci,E., Platz,E.A., Stampfer,M.J., Chan,A., Krithivas,K., Kawachi,I., Willett,W.C. and Kantoff,P.W. (1999) The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia. Urology, 53, 121-125.
30. Shibata,A., Stamey,T.A., McNeal,J.E., Cheng,I. and Peehl,D.M. (2001) Genetic polymorphisms in the androgen receptor and type II 5 alpha-reductase genes in prostate enlargement. J. Urol., 166, 1560-1564.
31. Bousema,J.T., Bussemakers,M.J., van-Houwelingen,K.P., Debruyne,F.M., Verbeek,A.L., de-La-Rosette,J.J. and Kiemeney,L.A. (2000) Polymorphisms in the vitamin D receptor gene and the androgen receptor gene and the risk of benign prostatic hyperplasia. Eur. Urol., 37, 234-238.
32. Xue,W.M., Coetzee,G.A., Ross,R.K., Irvine,R., Kolonel,L., Henderson,B.E. and Ingles,S.A. (2001) Genetic determinants of serum prostate-specific antigen levels in healthy men from a multiethnic cohort. Cancer Epidemiol. Biomarkers Prev., 10, 575-579.